China Test Concerns Keep Eli Lilly Cancer Drug Unapproved By FDA
Media outlets report that the Food and Drug Administration was concerned the only clinical trials of the lung cancer treatment happened in China in a population not as diverse as that in the U.S. Meanwhile, controversially-approved Alzheimer's drug Aduhelm is again in the news.